Endocrinology News and Research

Latest Endocrinology News and Research

Novo Nordisk BlueSheet launched to provide information on diabetes and chronic disease

Novo Nordisk, a global healthcare company and leader in diabetes care, today announced the launch of the Novo Nordisk BlueSheet, a resource for information on diabetes and chronic disease, highlighting key issues in diabetes prevention, detection, treatment and care.

30 Mar 2010

Neuroscientists prevent memory loss in fruit flies by blocking activity of PI3 kinase signaling protein

By blocking the cellular signaling activity of a protein, a team of neuroscientists at Cold Spring Harbor Laboratory (CSHL) has prevented memory loss in fruit flies caused by brain plaques similar to those thought to cause Alzheimer's disease in humans. The study also resolves a long-standing controversy about the role of this protein, PI3 kinase, which was previously thought to have a protective function against the disease.

30 Mar 2010

National Donate Life Month: Facts surrounding dire need for organ donations

With Thursday, April 1, 2010, marking the start of "National Donate Life Month," Health Net, Inc. is working to increase awareness regarding the urgent need for organ donations - particularly among minority populations - and also to dispute some of the misperceptions surrounding organ donation.

30 Mar 2010

Patients form new coalition to advocate for patients' rights and to fight health bureaucracy

For the first time in Canadian history patients met formally to voice their concerns about the way healthcare decisions are made.

30 Mar 2010

Preventive health care researchers meet to outline vision for evidence-based prevention in health care

Leading preventive health care researchers, physicians and executives assembled at U.S. Preventive Medicine® Friday to outline their vision for advancing evidence-based prevention in health care.

30 Mar 2010

Analysis indicates substantial underdiagnosis of obesity when BMI used compared to DEXA scan

A retrospective analysis of 1,234 Americans indicated a substantial underdiagnosis of obesity when Body Mass Index was used compared to the Dual Energy X-ray Absorptiometry scan. This analysis will be released on Friday, April 23, 2010 at the American Association of Clinical Endocrinologists 19th Annual Meeting & Clinical Congress in Boston.

30 Mar 2010

Mutations in gene protecting body leads to development of cancer

An important gene that normally protects the body against cancer can itself cause a variety of cancers depending on the specific mutation that damages it, according to a new study by investigators at the Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James).

30 Mar 2010

Few pregnant women meet physical activity guidelines set by health officials: Study

Fewer than 1 in 4 pregnant women meet physical activity guidelines set by doctors and health officials, according to a University of North Carolina at Chapel Hill study.

30 Mar 2010

Study: Hormone replacement in joint fluid might be beneficial in treating osteoarthritis

German researchers determined that concentrations of the sex hormones, testosterone in men and estrogen in women, may have a positive effect on the regenerative potential of cartilage tissue. The study suggests hormone replacement in the joint fluid of men and women might be beneficial in treating late stages of human osteoarthritis by regenerating damaged tissue.

30 Mar 2010

NICE appraisal committee publishes preliminary recommendation of Multaq for AF

Sanofi-aventis announced today that the National Institute for Health and Clinical Excellence (NICE) in England and Wales, has just published a new appraisal consultation document for Multaq(R) (dronedarone) indicating its intention to recommend Multaq(R) use for the management of patients with atrial fibrillation.

30 Mar 2010

CEO Roundtable on Cancer announces Gold Standard accreditation for Susan G. Komen for the Cure

Susan G. Komen for the Cure®, the world's largest breast cancer organization, has received CEO Cancer Gold Standard™ accreditation, recognizing the organization's commitment to reducing the risk of cancer for its employees and their families by promoting healthy lifestyle choices, by encouraging early detection through cancer screenings, and by ensuring access to quality treatment.

30 Mar 2010

Rite Aid, AAAAI team up to offer guides to allergy sufferers

Rite Aid and the American Academy of Allergy, Asthma & Immunology are again teaming up this spring to help allergy sufferers with free allergy guides available now in nearly 4,800 Rite Aid stores nationwide and online at www.riteaid.com.

30 Mar 2010

Dicerna Pharmaceuticals, Ipsen announce collaboration in DsiRNA research and peptide engineering

Dicerna Pharmaceuticals, Inc., (Dicerna) a second generation RNA interference (RNAi) company, and Ipsen, a global biotechnology specialty care group, announced today that the two companies have entered into an exclusive research collaboration agreement to leverage their expertise in Dicer Substrate siRNA (DsiRNA) research and peptide engineering. The companies will develop novel conjugates of Dicerna's DsiRNA molecules and Ipsen's peptide targeting vectors in the therapeutic areas of oncology and endocrinology.

30 Mar 2010

LCT receives approval for New Zealand Phase II human trial of DIABECELL

Living Cell Technologies Limited, a global company pioneering the development of a cell implant to treat diabetes, today announced that it has received approval to advance to the next phase of its New Zealand Phase II human clinical trial with its groundbreaking DIABECELL®. The approval follows a positive assessment from the New Zealand Data Safety and Monitoring Board of the first four patients to receive its DIABACELL® implants.

30 Mar 2010

Conference on the actions of Vitamin D on human health

An important conference on the actions of Vitamin D on human health is being hosted by Barts and The London Medical School and the MRC Asthma UK Centre in Allergic Mechanisms of Asthma.

30 Mar 2010

National Institute of Mental Health awards two-year, $998,940 grant for autism research

An average of one in 100 children in the United States has an autism spectrum disorder according to the Centers for Disease Control and Prevention. While over the last few years an increasing number of these children have begun to receive early intervention services, research shows that high quality and intensive intervention are critical for positive outcomes.

29 Mar 2010

Siemens Healthcare Diagnostics announces new contract with Premier Purchasing Partners

Siemens Healthcare Diagnostics announces a new three-year contract with Premier Purchasing Partners, L.P., the group purchasing unit of Premier Inc., that includes Siemens powerful integrated diagnostic systems, several specialty diagnostic instruments, and a comprehensive menu of diagnostic tests for Premier's more than 2,300 member hospitals and 64,000 additional healthcare sites.

29 Mar 2010

Generex Biotechnology announces FDA Expanded Access Treatment IND Program for Generex Oral-lyn

Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has expanded its plans for its United States Food and Drug Administration (FDA) Expanded Access Treatment IND Program for its flagship product, Generex Oral-lyn™, to include licensed and qualified Nurse Practitioners in the United States.

29 Mar 2010

Ligand Pharmaceuticals' LGD-4033 SARM Phase I study data featured at 14th endocrinology congress

Ligand Pharmaceuticals Incorporated today announced that data from a Phase I study with its selective androgen receptor modulator (SARM) LGD-4033 was featured today in a poster presentation at the 14th International Congress of Endocrinology in Kyoto, Japan. This Phase I clinical trial was the first study in humans of LGD-4033, and evaluated the safety, tolerability and pharmacokinetic profiles of the molecule in a single escalating dose, double blind, placebo-controlled study in 48 healthy volunteers.

29 Mar 2010

APP adds eClinicalWorks' EMR system to CI Program

In its continuing efforts to enhance patient outcomes and create efficiency in a challenging economic and regulatory climate, Advocate Physician Partners, has added the power of an electronic medical record system to its award-winning Clinical Integration Program. APP, the largest network of independent physicians in the Midwest, is partnering with eClinicalWorks® in one of the biggest EMR implementations in the country.

29 Mar 2010

Endocrinology News and Research

Latest Endocrinology News and Research

Novo Nordisk BlueSheet launched to provide information on diabetes and chronic disease

Neuroscientists prevent memory loss in fruit flies by blocking activity of PI3 kinase signaling protein

National Donate Life Month: Facts surrounding dire need for organ donations

Patients form new coalition to advocate for patients' rights and to fight health bureaucracy

Preventive health care researchers meet to outline vision for evidence-based prevention in health care

Analysis indicates substantial underdiagnosis of obesity when BMI used compared to DEXA scan

Mutations in gene protecting body leads to development of cancer

Few pregnant women meet physical activity guidelines set by health officials: Study

Study: Hormone replacement in joint fluid might be beneficial in treating osteoarthritis

NICE appraisal committee publishes preliminary recommendation of Multaq for AF

CEO Roundtable on Cancer announces Gold Standard accreditation for Susan G. Komen for the Cure

Rite Aid, AAAAI team up to offer guides to allergy sufferers

Dicerna Pharmaceuticals, Ipsen announce collaboration in DsiRNA research and peptide engineering

LCT receives approval for New Zealand Phase II human trial of DIABECELL

Conference on the actions of Vitamin D on human health

National Institute of Mental Health awards two-year, $998,940 grant for autism research

Siemens Healthcare Diagnostics announces new contract with Premier Purchasing Partners

Generex Biotechnology announces FDA Expanded Access Treatment IND Program for Generex Oral-lyn

Ligand Pharmaceuticals' LGD-4033 SARM Phase I study data featured at 14th endocrinology congress

APP adds eClinicalWorks' EMR system to CI Program

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Endocrinology News and Research

Latest Endocrinology News and Research

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in